{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-316947","form_type":"8-K","ticker":"NOVT","cik":"0001076930","company_name":"NOVANTA INC","filed_at":"2026-07-27T12:15:15+00:00","discovered_at":"2026-07-27T12:20:00.333581+00:00","generated_at":"2026-07-27T12:20:18.155393+00:00","sec_items":["2.01","1.01","2.03","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Novanta completes $1.2B acquisition of Riverpoint Medical; expects $0.18-$0.25 adjusted EPS accretion in 2027","bullets":["Acquired Riverpoint Medical for ~$1.2B cash at closing; additional $250M milestone payment due by Jan 8, 2027.","Funded with $616M in borrowings under credit facilities; total consolidated debt now $854.7M.","Deal expected to double recurring medical consumables revenue to ~$300M and push medical end-market to 60% of total revenue.","Expects $0.18-$0.25 adjusted EPS accretion in 2027, high single-digit ROIC by year three, and immediate accretion to margins.","Riverpoint is a category leader in minimally invasive surgical consumables for sports medicine, trauma, and cardiovascular applications."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-316947","json":"https://secwatch.observer/filing/0001193125-26-316947.json","markdown":"https://secwatch.observer/filing/0001193125-26-316947.md","text":"https://secwatch.observer/filing/0001193125-26-316947.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1076930/000119312526316947/0001193125-26-316947-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1076930/000119312526316947/novt-20260722.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-27T12:20:18.155393+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}